Interactive Investor
>>

Inventiva SA ADR (NASDAQ:IVA) Share Price

IVA

Inventiva SA ADR

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis and rare diseases. All the company's operations are located in France. The majority of the group's revenue is derived from its research partnerships with AbbVie and BI.Inventiva SA is a France-based clinical stage drug-discovery and development company.

NASDAQ:IVA

US46124U1079

USD

Loading...

Loading Comparison

Latest IVA News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News